Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.


Mayo Clinic researchers were among the first to describe primary sclerosing cholangitis. Other research done at Mayo has helped to refine diagnostic tests, improve treatment and assess the results of liver transplants for people with primary sclerosing cholangitis. Mayo Clinic researchers also developed mathematical models to help physicians predict long-term survival for people with primary sclerosing cholangitis.

Researchers at Mayo Clinic are currently studying the use of the fluorescence in situ hybridization (FISH) test in the diagnosis of bile duct cancer in people with primary sclerosing cholangitis. Another study is looking at genetic predisposition to primary sclerosing cholangitis.

Basic research related to primary sclerosing cholangitis and other liver diseases is conducted in the following Mayo Clinic laboratories:


See a list of publications on primary sclerosing cholangitis by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.